ストックスクリーナーアプリを入手
23.35
3.39%
-0.82
前日終値:
$24.17
開ける：
$24.17
24時間の取引高:
1.10M
Relative Volume:
0.85
時価総額：
$2.64B
収益：
$4.02M
当期純損益:
$-224.59M
株価収益率:
-9.813
EPS:
-2.3795
ネットキャッシュフロー:
$-205.52M
1週間 パフォーマンス:
-1.10%
1か月 パフォーマンス:
+28.58%
6か月 パフォーマンス:
+10.82%
1年 パフォーマンス:
+160.89%
1日の値動き範囲:
$22.27
$24.23
1週間の範囲:
$22.27
$25.00
52週間の値動き範囲:
$7.96
$27.65
Immunome Inc Stock (IMNM) Company Profile
Compare IMNM vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
23.35 | 2.64B | 4.02M | -224.59M | -205.52M | -2.3795 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-12 | 開始されました | H.C. Wainwright | Buy |
| 2025-12-01 | 開始されました | Truist | Buy |
| 2025-09-22 | 開始されました | Goldman | Buy |
| 2025-09-05 | 開始されました | Craig Hallum | Buy |
| 2025-04-02 | 開始されました | Lake Street | Buy |
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-31 | 開始されました | Piper Sandler | Overweight |
| 2024-04-30 | 開始されました | JP Morgan | Overweight |
| 2024-04-15 | 開始されました | Guggenheim | Buy |
| 2024-01-29 | 開始されました | Leerink Partners | Outperform |
| 2023-12-19 | 開始されました | Wedbush | Outperform |
| 2021-10-29 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Immunome Inc (IMNM) 最新ニュース
What Do Recent Insider Sales at Immunome (IMNM) Signal - Kavout | AI
Why Immunome (IMNM) Is Up 11.7% After FDA Accepts Varegacestat NDA For Desmoid Tumors - Sahm
Immunome Stock Up 32% in a Month: Here's What You Should Know - Yahoo Finance Singapore
symbol__ Stock Quote Price and Forecast - CNN
Form 4 Immunome Inc For: 9 July By Investing.com - Investing.com South Africa
Immunome CBO Horn Kinney sells $27,300 in stock By Investing.com - Investing.com South Africa
Truist Financial Maintains Immunome(IMNM.US) With Buy Rating - Moomoo
Immunome CBO Horn Kinney sells $27,300 in stock - Investing.com UK
Immunome Inc. (IMNM) CBO exercises options and sells 1,092 shares - Stock Titan
H.C. Wainwright reiterates Immunome stock rating on FDA filing By Investing.com - Investing.com India
Immunome Clears Key Regulatory Milestone as Lead Drug Goes Under FDA Review - Benzinga
Immunome secures FDA review for cancer drug varegacestat - grafa.com
LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Immunome granted FDA review for tumor candidate (IMNM:NASDAQ) - Seeking Alpha
FDA accepts Immunome NDA for desmoid tumor treatment varegacestat - Investing.com
FDA accepts Immunome NDA for desmoid tumor treatment varegacestat By Investing.com - Investing.com India
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors - Caledonian Record
Price-Driven Insight from (IMNM) for Rule-Based Strategy - Stock Traders Daily
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 7, 2026 - BioSpace
Immunome director Isaac Barchas sells $2.4m in shares, price $24.11-$24.20 - Investing.com
Form 4 Immunome Inc For: 7 July By Investing.com - Investing.com Nigeria
Immunome director Isaac Barchas sells $2.4m in shares, price $24.11-$24.20 By Investing.com - Investing.com South Africa
Form 144 Immunome Inc. For: 7 July By Investing.com - Investing.com India
Entity tied to Immunome (IMNM) director sells 100K shares - Stock Titan
Immunome CMO Robert Lechleider sells $1.24m in company stock - Investing.com
Immunome CMO Robert Lechleider sells $1.24m in company stock By Investing.com - Investing.com Nigeria
Immunome (IMNM) CMO exercises 55K options and sells 55K shares under 10b5-1 plan - Stock Titan
[144] Immunome Inc. SEC Filing - Stock Titan
Form 144 Immunome For: 6 July By Investing.com - Investing.com Nigeria
IMNM (Nasdaq) affiliate filings report multiple share sales, including 100,000-share entries - Stock Titan
Immunome's $4.39 Million Insider Sale: A Pre-Planned Exit Amidst Robust Pipeline Momentum - Kavout | AI
Immunome(IMNM.US) Director Sells US$4.39 Million in Common Stock - Moomoo
Form 4 Immunome Inc For: 2 July By Investing.com - Investing.com Nigeria
Immunome director Barchas sells $4.39m in common stock By Investing.com - Investing.com India
Director-linked entities trim Immunome (IMNM) stake with 201,050-share sale - Stock Titan
Immunome director Barchas sells $4.39m in common stock - Investing.com
Form 144 Immunome For: 2 July By Investing.com - Investing.com UK
IMNM (Nasdaq: IMNM) Rule 144 entries show 100,000-share block - Stock Titan
Form 144 Immunome Inc. For: 2 July By Investing.com - Investing.com UK
IMNM (NASDAQ: IMNM) affiliate files to sell 55,000 shares on 07/02/2026 - Stock Titan
Is Immunome’s (IMNM) Russell Exit Quietly Recasting Its Shareholder Base And Liquidity Story? - simplywall.st
Form 144 Immunome For: 30 June By Investing.com - Investing.com South Africa
J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating - Moomoo
Immunome CMO Robert Lechleider sells $1.09m in stock By Investing.com - Investing.com South Africa
Immunome Inc (IMNM) 財務データ
収益
当期純利益
現金流量
EPS
Immunome Inc (IMNM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Horn Kinney | CHIEF BUSINESS OFFICER |
Jul 07 '26 |
Sale |
25.00 |
1,092 |
27,300 |
0 |
| Barchas Isaac | Director |
Jul 06 '26 |
Sale |
24.11 |
83,094 |
2,003,396 |
125,410 |
| Barchas Isaac | Director |
Jul 07 '26 |
Sale |
24.20 |
16,906 |
409,125 |
108,504 |
| Lechleider Robert | Chief Medical Officer |
Jul 02 '26 |
Option Exercise |
8.73 |
55,000 |
480,150 |
70,805 |
| Lechleider Robert | Chief Medical Officer |
Jul 02 '26 |
Sale |
22.62 |
55,000 |
1,244,331 |
15,805 |
2.64%
大文字化:
|
ボリューム (24 時間):